Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-417-8 | CAS number: 106-63-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16.07.2001-13.11.2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Isobutyl acrylate
- EC Number:
- 203-417-8
- EC Name:
- Isobutyl acrylate
- Cas Number:
- 106-63-8
- Molecular formula:
- C7H12O2
- IUPAC Name:
- isobutyl acrylate
Constituent 1
- Specific details on test material used for the study:
- - Name of test material: Isobutyl acrylate
- Lot/batch No.: S 122-01-GA
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd. Biotechnology and Animal Breeding Division; CH-4414 Fuellinsdorf
- Age at study initiation: 8-10 weeks
- Weight at study initiation: males: mean 44.9 g; females: mean 33.6 g
- Housing: single
- Diet: pelleted standard diet, ad libitum
- Water: Tap water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 +/- 4
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle/solvent used: olive oil, O1500, Sigma-Aldrich Vertriebs-GmbH
- Amount of vehicle: 10 mL/kg - Duration of treatment / exposure:
- single injection; harvesting of cells 24 and 48 hours after administration of test substance
- Frequency of treatment:
- single treatment
Doses / concentrationsopen allclose all
- Dose / conc.:
- 250 mg/kg bw/day (nominal)
- Remarks:
- males/ 24 hours harvesting
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Remarks:
- males/ 24 hours harvesting
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- males/ 24 hours harvesting
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- males/ 48 hours harvesting
- Dose / conc.:
- 312.5 mg/kg bw/day (nominal)
- Remarks:
- female/ 24 hours harvesting
- Dose / conc.:
- 625 mg/kg bw/day (nominal)
- Remarks:
- female/ 24 hours harvesting
- Dose / conc.:
- 1 250 mg/kg bw/day (nominal)
- Remarks:
- female/ 24 hours harvesting
- Dose / conc.:
- 1 250 mg/kg bw/day (nominal)
- Remarks:
- female/ 48 hours harvesting
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- yes, historical
- Positive control(s):
- cyclophosphamide, 40 mg/kg bw, i.p.
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Dose selection: on basis of the results from a pre-experiment.
TREATMENT:
10 animals per group were evaluated for micronuclei. At least 2000 polychromatic erythrocytes (PCE) per animal were scored. Cytotoxicity was evaluated by the ratio of polychromatic to normochromatic erythrocytes (determined in the same samples as used for micronuclei scoring).
- Evaluation criteria:
- A test substance is classified as mutagenic if it induces either a dose-related increase in the number of micronucleated polychromatic erythrocytes, which clearly exceeds the negative control range or a relevant positive response for at least one of the test points.
Statistical methods (nonparametric Mann-Whitney test) can be used as an aid in evaluating the results. However, the primary point of consideration is the biological relevance of the results.
A test substance producing neither a dose-related increase in the number of micronucleated polychromatic erythrocytes nor a positive response at any of the test points is considered non-mutagenic in this system. - Statistics:
- A non-parametric Mann-Whitney-Test was performed.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Clinical signs in the high dose animals
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: male: 0, 1250 mg/kg bw; female: 0, 1500 mg/kg bw
- Clinical signs of toxicity in test animals: In the dose range-finder pre-experiment, 1250 mg/kg bw i.p. were lethal to both tested male animals. In females, 1500 mg/kg bw i.p. were lethal for 1 of 2 animals.
RESULTS OF DEFINITIVE STUDY
The test item did not induce micronuclei at any dose level or any harvesting time used in this study. It was considered non-clastogenic and non-aneugenic in this assay.
The mean number of normochromatic erythrocytes was not increased after treatment with the test substance as compared to the controls, indicating that the test item had no cytotoxic effect on the bone marrow. The positive control substance induced a distinct increase of micronuclei.
- Clinical signs of toxicity in test animals: males at 1000 mg/kg bw: reduced spontaneous activity, eyelid closure, apathy, prostrate position. females at 1250 mg/kg bw: reduced spontaneous activity, eyelid closure, apathy, prostrate position. 1000 mg/kg bw induced clear signs of toxicity in 7 male animals (reduced activity, eyelid closure, apathy, prostrate position). In females, at 1250 mg/kg bw clear signs of toxicity were observed in 7 female animals (reduced activity, eyelid closure, apathy, prostrate position).
Any other information on results incl. tables
Summary of Micronucleus Test Results
Males
Test group |
dose (mg/kg bw) |
sampling time (h) |
PCEs with micronuclei (‰) |
range |
PCE / NCE |
vehicle |
0 |
24 |
1.20 |
2 - 3 |
2000 / 1965 |
test substance |
250 |
24 |
0.60 |
0 - 3 |
2000 / 1888 |
test substance |
500 |
24 |
0.60 |
0 - 3 |
2000 / 2141 |
test substance |
1000 |
24 |
1.20 |
1 - 4 |
2000 / 2371 |
positive control |
40 |
24 |
14.90 |
17 - 36 |
2000 / 1771 |
vehicle |
0 |
48 |
0.00 |
0 - 0 |
2000 / 2022 |
test substance |
1000 |
48 |
0.40 |
0 - 2 |
2000 / 2642 |
Females:
Test group |
dose (mg/kg bw) |
sampling time (h) |
PCEs with micronuclei (‰) |
range |
PCE / NCE |
vehicle |
0 |
24 |
0.10 |
0 - 1 |
2000 / 1965 |
test substance |
312.5 |
24 |
0.50 |
0 - 3 |
2000 / 1888 |
test substance |
625 |
24 |
0.40 |
0 - 3 |
2000 / 2141 |
test substance |
1250 |
24 |
0.20 |
0 - 2 |
2000 / 2371 |
positive control |
40 |
24 |
12.10 |
11 - 43 |
2000 / 1771 |
vehicle |
0 |
48 |
0.00 |
0 - 0 |
2000 / 2022 |
test substance |
1250 |
48 |
0.10 |
0 - 21 |
2000 / 2642 |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.